Submitted by Anonymous (not verified) on 6 November 2023 - 14:50
Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Hypercholesterolemia, Date of authorisation: 31/07/2013, Revision: 18, Status: Authorised
Source: